Lytix Biopharma AS (6BG) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ltx-315 In Combination With Pembrolizumab | Advanced Melanoma | Phase II | Unknown | Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma | Mar 02, 2021 | ― |
| Ltx-315 And Tils | Soft Tissue Sarcoma | Phase II | Completed | LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04) | Oct 02, 2018 | ― |
| Ltx-315 Consecutive Lesions, Ltx-315, Ltx-315 + Ipilimumab, Ltx-315 + Pembrolizumab | Cancer, Breast Cancer, Melanoma, Lymphoma, Head And Neck Cancer, Triple-Negative Breast Cancer | Phase I | Completed | LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab | Oct 28, 2013 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ltx-315 In Combination With Pembrolizumab | Phase II | Advanced Melanoma | Unknown | Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma | Mar 02, 2021 | ― |
| Ltx-315 And Tils | Phase II | Soft Tissue Sarcoma | Completed | LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04) | Oct 02, 2018 | ― |
| Ltx-315 Consecutive Lesions, Ltx-315, Ltx-315 + Ipilimumab, Ltx-315 + Pembrolizumab | Phase I | Cancer, Breast Cancer, Melanoma, Lymphoma, Head And Neck Cancer, Triple-Negative Breast Cancer | Completed | LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab | Oct 28, 2013 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lytix Biopharma AS (DE:6BG) have in its pipeline
Lytix Biopharma AS DE:6BG is currently developing the following drugs: Ltx-315 In Combination With Pembrolizumab, Ltx-315 And Tils, Ltx-315 Consecutive Lesions, Ltx-315, Ltx-315 + Ipilimumab, Ltx-315 + Pembrolizumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
